| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mi | mAbxience, OncoPrecision Agree to Advance Lead ADC Candidate | ||
| Mi | FDA Approves GSK Treatment for ALK-Positive NSCLC | ||
| Mi | Shionogi Closes $2B IntraBio Deal, Adds Rare Disease Drug AQNEURSA | ||
| Mi | Lotte Biologics Marks Completion of Songdo Bio Campus Plant 1 | ||
| Mi | Thermo Fisher Launches New Medium for Adenovirus Vaccine Production | ||
| Mi | GeneDx Taps Everett Cunningham as CEO | ||
| Mi | Pfizer Bets $330M on Starna's In Vivo CAR-T Programs for Autoimmune Diseases | ||
| Di | Made Scientific, Orca Bio Reach Long-Term Pact for Tregzi Manufacturing | ||
| Di | OXB, Aura to Partner on Phase III Development, Future Supply of Oncology Candidate | ||
| Di | TreeFrog Therapeutics Appoints James Sterling as CFO | ||
| Di | Lotte Biologics Agrees to Major Manufacturing Deal with Global Pharma Company | ||
| Di | Gene2Cure, Viralgen Partner to Advance Gene Therapies for Rare Pediatric Diseases | ||
| Di | Qosina Launches Redesigned Website | ||
| Di | Gilead Inks Deals with Dr. Reddy's, Eva Pharma, Ferozsons to Expand Ebola BVD Treatment | ||
| Di | argenx Expands Cradle AI Platform for Antibody Discovery | ||
| Di | Körber Launches Integrated Pharma Packaging Line for Vials and Syringes | ||
| Di | Three Developers Tap AGC Biologics' New Yokohama Cell Therapy Site | ||
| Di | 10x Genomics Expands Autoimmune Diagnostics Research Through Global Partnerships | ||
| Mo | CorePharma Adds Spray Drying Platform for Poorly Soluble APIs | ||
| Mo | Biocon's Pebrilzo, A Perjeta Biosimilar, Approved by FDA for HER2+ Breast Cancer | ||
| Mo | AmyriAD Acquires ADvantage Alzheimer's Program, Boosting Clinical-Stage Pipeline | ||
| Mo | Biomapas Enters US Market with Acquisition of Alira Health's CMC Business | ||
| Mo | Biogen, Trimtech Partner on Neurodegenerative Disease Degraders | ||
| Mo | J&J to Acquire Ollin Biosciences in $2.2B Ophthalmology Deal | ||
| Mo | Aptamer Names James McNamara Head of Oligonucleotide Therapeutic Development |